We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Hyperbaric Oxygen Therapy Relieves RT Side Effects

By HospiMedica International staff writers
Posted on 30 Oct 2019
Hyperbaric oxygen therapy (HBOT) reduces the self-reported symptoms and side effects of cancer radiotherapy (RT) in the pelvic region, according to a new study.

Researchers at Angereds Hospital (Sweden), Sahlgrenska Academy (SA; Göteborg, Sweden), Haukeland University Hospital (Bergen, Norway), and other institutions conducted a randomized, controlled trial at five Nordic hospitals involving 87 patients (18–80 years of age) with pelvic RT who were referred to a HBOT clinic due to symptoms of late radiation cystitis. More...
Patients were randomly assigned to either HBOT (42 patients) or to standard care with no restrictions for other medications or interventions (45 patients).

The HBOT patients received 30–40 sessions of 100% oxygen breathed at a pressure of 240–250 kPa, for 80–90 min daily. The primary outcome was change in patient-perceived urinary symptoms assessed with the expanded prostate index composite score (EPIC), from inclusion to follow-up at visit four, held six to eight months later. The results revealed a change in EPIC urinary total score at visit 4 of 10.1 points in the HBOT group, compared to 7.7 points in the standard care group. In all, 41% of the HBOT patients experienced transient adverse events related to sight and hearing during the treatment period. The study was published on September 17, 2019, in The Lancet Oncology.

“In the patients in the study, general health was greatly impaired before treatment, sometimes after long periods of discomfort,” said lead author Nicklas Oscarsson, MD, of Angered Hospital, and a doctoral student in anesthesiology and intensive care at Sahlgrenska Academy. “If a patient no longer needed morphine for pain, or was able to go to the toilet once a night instead of five times, it was a clear improvement. It's a great pleasure to hear patients tell us how they feel they're returning to a normal human life. This also applies to those who get better, but perhaps aren't entirely well.”

RT is part of many treatment protocols of cancer in organs such as the prostate, cervix, ovaries, and colon. One side effect of RT in the lower abdomen is damage of nearby, healthy tissue such as the urinary tract, bladder, vagina or rectum. Symptoms such as a frequent urge to urinate, incontinence, bleeding, and severe abdominal pain may arise immediately following or even several years after RT, causing chronic and often increasing discomfort.

Related Links:
Angereds Hospital
Sahlgrenska Academy
Haukeland University Hospital


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Syringe Pump
SP50 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: 123RF

AI-Enhanced Handheld Ultrasound Improves Carotid Plaque Detection

Handheld ultrasound can miss small or faint carotid plaque, creating uncertainty in community screening. This gap makes it harder for frontline clinicians to decide who needs confirmatory imaging, closer... Read more

Surgical Techniques

view channel
Image: Associate Professor Menglin Chen studies how the light-sensitive nanoparticles affect living cells. The screen shows calcium being released inside a cell after nanoparticles taken up by the cell are exposed to blue light. Calcium plays an important role in cellular signaling, and the experiment helps the researchers understand how the nanoparticles can translate light into biological activity. (Photo courtesy of Aarhus University, Johanne Holm Jensen)

Light-Activated Nanoparticles May Offer New Approach to Retinal Prostheses

Retinitis pigmentosa is a degenerative retinal disorder in which photoreceptors progressively die, reducing visual signals to the brain while leaving surviving inner retinal circuits underused.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.